Cancer Research UK logo.
SearchDonate
  • Search

A trial of atezolizumab for urothelial cancer (urinary tract cancer) after surgery (W029636)

Overview

Cancer types:

Bladder cancer

Status:

Closed

Phase:

Phase 3

Details

This trial is for people whose cancer has grown into the muscle layer of the bladder or upper urinary tract (invasive urothelial cancer). And whose cancer hasn't spread elsewhere in the body.

The urinary tract includes the:

  • centre of the kidney (renal pelvis)

  • tube that takes urine from the kidneys to the bladder (ureter)

  • bladder

Recruitment start: 3 November 2015

Recruitment end: 31 May 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Alison Birtle

Supported by

Experimental Cancer Medicine Centre (ECMC)

Roche

Last reviewed: 30 May 2018

CRUK internal database number: 13931

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.